These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 25224324)
1. POLE mutations as an alternative pathway for microsatellite instability in endometrial cancer: implications for Lynch syndrome testing. Konstantinopoulos PA; Matulonis UA Cancer; 2015 Feb; 121(3):331-4. PubMed ID: 25224324 [No Abstract] [Full Text] [Related]
3. Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer. Stasenko M; Tunnage I; Ashley CW; Rubinstein MM; Latham AJ; Da Cruz Paula A; Mueller JJ; Leitao MM; Friedman CF; Makker V; Soslow RA; DeLair DF; Hyman DM; Zamarin D; Alektiar KM; Aghajanian CA; Abu-Rustum NR; Weigelt B; Cadoo KA Gynecol Oncol; 2020 Jan; 156(1):194-202. PubMed ID: 31757464 [TBL] [Abstract][Full Text] [Related]
4. Endometrial Carcinomas with a "Serous" Component in Young Women Are Enriched for DNA Mismatch Repair Deficiency, Lynch Syndrome, and POLE Exonuclease Domain Mutations. Conlon N; Da Cruz Paula A; Ashley CW; Segura S; De Brot L; da Silva EM; Soslow RA; Weigelt B; DeLair DF Am J Surg Pathol; 2020 May; 44(5):641-648. PubMed ID: 32205482 [TBL] [Abstract][Full Text] [Related]
5. An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer. Cosgrove CM; Tritchler DL; Cohn DE; Mutch DG; Rush CM; Lankes HA; Creasman WT; Miller DS; Ramirez NC; Geller MA; Powell MA; Backes FJ; Landrum LM; Timmers C; Suarez AA; Zaino RJ; Pearl ML; DiSilvestro PA; Lele SB; Goodfellow PJ Gynecol Oncol; 2018 Jan; 148(1):174-180. PubMed ID: 29132872 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of POLE Exonuclease Domain Mutations in High-Grade Endometrioid Endometrial Cancer on Survival and Recurrence: A Subanalysis. Billingsley CC; Cohn DE; Mutch DG; Hade EM; Goodfellow PJ Int J Gynecol Cancer; 2016 Jun; 26(5):933-8. PubMed ID: 26937754 [TBL] [Abstract][Full Text] [Related]
12. Endometrial cancer with a POLE mutation progresses frequently through the type I pathway despite its high-grade endometrioid morphology: a cohort study at a single institution in Japan. Monsur M; Yamaguchi M; Tashiro H; Yoshinobu K; Saito F; Erdenebaatar C; Li C; Iwagoi Y; Ohba T; Iyama KI; Katabuchi H Med Mol Morphol; 2021 Jun; 54(2):133-145. PubMed ID: 33399963 [TBL] [Abstract][Full Text] [Related]
13. Primum non nocere: Are we ready for POLE testing in endometrial cancer? Cosgrove CM; Cohn DE; Goodfellow PJ Gynecol Oncol; 2017 Nov; 147(2):240-242. PubMed ID: 28947175 [No Abstract] [Full Text] [Related]
14. POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium. Meng B; Hoang LN; McIntyre JB; Duggan MA; Nelson GS; Lee CH; Köbel M Gynecol Oncol; 2014 Jul; 134(1):15-9. PubMed ID: 24844595 [TBL] [Abstract][Full Text] [Related]
15. Mutation spectrum of POLE and POLD1 mutations in South East Asian women presenting with grade 3 endometrioid endometrial carcinomas. Wong A; Kuick CH; Wong WL; Tham JM; Mansor S; Loh E; Jain S; Vikas NN; Tan SH; Chan SH; Li ST; Chew SH; Hong W; Ngeow J Gynecol Oncol; 2016 Apr; 141(1):113-20. PubMed ID: 26748215 [TBL] [Abstract][Full Text] [Related]
16. Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma. Hoang LN; McConechy MK; Köbel M; Anglesio M; Senz J; Maassen M; Kommoss S; Meng B; Postovit L; Kelemen LE; Staebler A; Brucker S; Krämer B; McAlpine JN; Gilks CB; Huntsman DG; Lee CH Int J Gynecol Cancer; 2015 Sep; 25(7):1187-93. PubMed ID: 26166557 [TBL] [Abstract][Full Text] [Related]
17. Two cases of endometrial cancer meeting new clinical criteria for hereditary nonpolyposis colorectal cancer. Sagawa T; Yamada H; Yamamoto R; Sakuragi N; Fujimoto S Gynecol Oncol; 2000 Nov; 79(2):327-31. PubMed ID: 11063667 [TBL] [Abstract][Full Text] [Related]
18. A potpourri of pathogenetic pathways in endometrial carcinoma with a focus on Lynch Syndrome. Wadee R; Grayson W Ann Diagn Pathol; 2019 Apr; 39():92-104. PubMed ID: 30798077 [TBL] [Abstract][Full Text] [Related]
20. The clinicopathology and survival characteristics of patients with POLE proofreading mutations in endometrial carcinoma: A systematic review and meta-analysis. Jumaah AS; Al-Haddad HS; McAllister KA; Yasseen AA PLoS One; 2022; 17(2):e0263585. PubMed ID: 35139130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]